While the investigated immune alterations post-stroke had promptly reversed in the improved cohort, HMGB-1 concentrations were not differentially regulated between the improved and non-improved cohort at the investigated time points (Figure 3D). This evidence concerns the gene HMGB1 and stroke disorder.